(Q44054640)

English

Relations of lipoprotein subclass levels and low-density lipoprotein size to progression of coronary artery disease in the Pravastatin Limitation of Atherosclerosis in the Coronary Arteries (PLAC-I) trial

scientific article published in July 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Relations of lipoprotein subclass levels and low-density lipoprotein size to progression of coronary artery disease in the Pravastatin Limitation of Atherosclerosis in the Coronary Arteries (PLAC-I) trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

atherosclerosis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

coronary artery disease

1 reference

based on heuristic

inferred from title

author name string

Robert S Rosenson

1

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

James D Otvos

2

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

David S Freedman

3

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

language of work or name

0 references

publication date

1 July 2002

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

American Journal of Cardiology

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

90

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

89-94

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Pravastatin limitation of atherosclerosis in the coronary arteries (PLAC I): Reduction in atherosclerosis progression and clinical events

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902427-X

7 January 2021

Effects of pravastatin treatment on lipoprotein subclass profiles and particle size in the PLAC-I trial

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902427-X

7 January 2021

Comparison of various electrophoretic characteristics of LDL particles and their relationship to the risk of ischemic heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902427-X

7 January 2021

Lipid lowering, regression, and coronary events. A review of the Interdisciplinary Council on Lipids and Cardiovascular Risk Intervention, Seventh Council meeting.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902427-X

7 January 2021

Lipoprotein subclasses in the Monitored Atherosclerosis Regression Study (MARS). Treatment effects and relation to coronary angiographic progression

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902427-X

7 January 2021

Evidence for a new pathophysiological mechanism for coronary artery disease regression: hepatic lipase-mediated changes in LDL density

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902427-X

7 January 2021

LDL particle size distribution is associated with carotid intima-media thickness in healthy 50-year-old men.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902427-X

7 January 2021

Accumulation of lipoprotein fractions and subfractions in the arterial wall, determined in an in vitro perfusion system

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902427-X

7 January 2021

Phospholipase A2 and small, dense low-density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902427-X

7 January 2021

Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902427-X

7 January 2021

Low-density lipoprotein size, pravastatin treatment, and coronary events.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902427-X

7 January 2021

Is the size of low-density lipoprotein particles related to the risk of coronary heart disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902427-X

7 January 2021

Relation of lipoprotein subclasses as measured by proton nuclear magnetic resonance spectroscopy to coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902427-X

7 January 2021

Alterations in the concentration of an apolipoprotein E-containing subfraction of plasma high density lipoprotein in coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902427-X

7 January 2021

High density lipoproteins and coronary atherosclerosis. A strong inverse relation with the largest particles is confined to normotriglyceridemic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902427-X

7 January 2021

Distribution of ApoA-I-containing HDL subpopulations in patients with coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902427-X

7 January 2021

Associations between lipoproteins and the progression of coronary and vein-graft atherosclerosis in a controlled trial with gemfibrozil in men with low baseline levels of HDL cholesterol

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902427-X

7 January 2021

How high-density lipoprotein protects against the effects of lipid peroxidation

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902427-X

7 January 2021

HDL and the inflammatory response induced by LDL-derived oxidized phospholipids

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902427-X

7 January 2021

Atherogenesis: a postprandial phenomenon

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902427-X

7 January 2021

Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902427-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Associations of lipoproteins and apolipoproteins with gradient gel electrophoresis estimates of high density lipoprotein subfractions in men and women

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902427-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0002-9149(02)02427-X

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44054640&oldid=2106077277"